All episodes
Not scored yet7m·2025-07-21·Business
How can India’s pharma companies survive under Trump’s uncertainty?
Finshots Daily
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
Buzzmeter · cross-platform
Not scored yet
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
Recent reviews
- No reviews yet — be the first.
Similar episodes from other shows
More like Finshots Daily →
Not scored yet
Why Indian pharma isn't scared of a 100% tariff (yet)
Daybreak
17m ·
Not scored yet
The Chinese Cancer Fix
The Morning Brief
13m ·
Not scored yet
Indian pharma: lofty aims in the midst of chaos
The Daily Brief
23m ·
Not scored yet
Challenges of trading with China, India's cancer map, and GST 2.0
3 Things
33m ·
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.